Embolx, Inc. a medical device company developing microcatheters for arterial embolization procedures, announced that the company has filed a 510(k) to the Food and...
Astellas Pharma Inc. announced plans to create an integrated biotechnology campus in South San Francisco as its West Coast innovation and research center. The...
Xandar Kardian, a rapidly-growing, Toronto-based company that develops contactless health monitoring solutions powered by digital ultra wide-band radar signal processing, officially announced a strategic...
Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras.
The decision to discontinue the development of fezagepras is...
ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates that address unmet medical needs in the...
